http://www.bing.com:80/search?q=Masimo+SpO2+Security+PlateSearch resultshttp://www.bing.com:80/s/a/rsslogo.gifhttp://www.bing.com:80/search?q=Masimo+SpO2+Security+PlateCopyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.https://www.masimo.com/Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors.Sat, 27 Jun 2026 11:06:00 GMThttps://en.wikipedia.org/wiki/MasimoMasimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings.Sat, 27 Jun 2026 00:15:00 GMThttps://investors.danaher.com/2026-02-17-Danaher-To-Acquire-Masimo-CorporationDanaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: MASI) a leading...Sat, 27 Jun 2026 06:12:00 GMThttps://www.medtechdive.com/news/whats-next-Masimo-CEO-Kiani/726553/What’s next at Masimo after CEO Kiani’s exit? Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation of its consumer business could play out.Sun, 29 Sep 2024 23:55:00 GMThttps://www.fiercebiotech.com/medtech/danaher-buys-patient-monitoring-specialist-masimo-99-billion-dealDanaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio.Wed, 18 Feb 2026 03:02:00 GMThttps://www.biotechreality.com/2026/06/danaher-acquisition-of-masimo.htmlThe official Danaher acquisition of Masimo is completed, integrating advanced pulse oximetry and AI-enabled patient monitoring into its diagnos...Sat, 27 Jun 2026 00:15:00 GMThttps://www.mpo-mag.com/breaking-news/danaher-closes-9-9b-acquisition-of-masimo/Masimo will continue to operate under its own brand and will be a standalone operating company in Danaher’s Diagnostics segment.Thu, 25 Jun 2026 17:28:00 GMThttps://www.mymasimo.com/Learn how to use the Masimo SafetyNet monitoring system, including setting up the mobile app and applying a sensor, with simple instructions and videosFri, 26 Jun 2026 04:05:00 GMThttps://www.fool.com/investing/2026/06/24/danaher-is-down-22-this-year-is-the-masimo-acquisi/The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from traditional laboratory testing into patient-connected, real-time data streams.Wed, 24 Jun 2026 18:40:00 GMThttps://markets.financialcontent.com/stocks/article/marketminute-2026-2-17-danahers-99-billion-bet-masimo-acquisition-to-redefine-the-diagnostics-landscapeSummary and Market Outlook The Danaher-Masimo deal is a landmark $9.9 billion transaction that marks the end of an era for Masimo as an independent entity and the beginning of a new chapter for Danaher’s diagnostic ambitions.Sat, 27 Jun 2026 15:59:00 GMT